The Dell-backed software management technology provider was valued at $1.5bn as of October and has initially filed to raise $100m.

TearClear has raised $34.8m to date to fund an anti-preservative eye drop technology invented at University of Florida.

Baxter Ventures is set to exit the kidney dialysis device maker, which has just filed to go public following upwards of $430m in venture funding.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The protein degradation drug developer's valuation has rocketed following an offering that achieved exits for Vertex Pharmaceuticals, Pfizer, Sanofi, Amgen and Merck & Co.

CapitalG, which joined Dataiku’s shareholders through a secondary transaction last year, has now made its first primary investment in the data management software provider.

Gigafund led a series C round for the GV and Stripe-backed online coding school to increase its overall funding to approximately $122m.

GlaxoSmithKline’s Action Potential Venture Capital fund led a series B-plus round that included TDK Ventures, Intel Capital and Applied Ventures.

Boston Children’s Hospital, Blue Cross Blue Shield of Massachusetts and Blue Shield of California have all invested in the children's behavioural healthcare provider.

Digital Garage-backed software pentesting service Cobalt.io pushed its total funding to more than $36m in a Highland Europe-led series B round.